Introduction to SLE Flashcards

1
Q

What is the gender ratio in SLE?

A

F:M 8:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the key questions in differentiated SLE from other diseases that cause fatigue; joint pains etc?

A

Photosensitivity; Raynauds; malar rash; oral ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What drug can cause SLE?

A

hydralazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does frothy urine indicate?

A

high protein content

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is classically seen in SLE with CRP and ESR?

A

normal CRP but high ESR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is seen on FBC with SLE?

A

lots of paenias- low Hb; WBC; platelts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What antibodies are found in SLE?

A

ANA; extractable nuclear antigen; dsDNA; antiphospholipid antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the antiphospholipid antibodies?

A

lupus anticoagulant; anticardiolipin; anti-glycoprotein b2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the sensitivity/specifiity of ANA?

A

high sensitivity but low specificity (if don’t have ANA don’t have lupus, but ANA doesn’t mean you have)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the cuntaeous manifestations of lupus?

A

alopecia; malar rash; oral/nasal ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Give exanmples of extractable nuclear antigens?

A

anti-Ro; anti-La; anti-Smith

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What proportion of lupus patients will develop lupus nephritis?

A

upto 2/3rds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the pathogenesis of lupus nephritis?

A

circulating IC deposited, complement activation, pro-inflam cytokines, infiltration of lymphocytes nad macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is lupus nephritis diagnosed?

A

kidney biopsy- LM; IF; EM; clinical features; serological features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why may some patietns with lupus go into long term remission?

A

immune exhaustion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is vitamin D important in lupus?

A

tolerogenic for Dcs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How is hydroxychloroquine thought to work in SLE?

A

by affecting TLRs and TNFa which is key to DC activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is complete response in lupus nephritis?

A

proteinuria <50mg/mmol and goood renal function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What may be the problem with rituximab in treating SLE?

A

reduces B cells which increases BAFF levels, then when B cells come back its to a very activating envionrmnet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is seen in B cells in lupus patients?

A

not increased numbers but increased proliferation and increased spontaneously secreted IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What can maybe fix the problem with rituximab in SLE?

A

giving rituximab followed by belimumab (anti-BAFF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which patients receiving rituximab get a complete reposnse?

A

those with complete peripheral B cell depletion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is SLE characterised by immunlogically?

A

global loss of self-tolerance with activation of autoreactive T and B cells leading to production of pathogenic autoantibodies and tissue injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What showed that DCs are key in the pathogenesis of SLE?

A

in mouse model of lupus, DC-deficient mice exhibited less severe disease than DC-intact models

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How do activated neutrophils die?

A

NETosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the feed forward loop of neutrophils and NETs?

A

IFNa in SLE activate neutrophils who release NETs which then are available for TLR-directed pDC activation and IFN release which then prime further neutrophils and aid cDC maturation with autreactive T cell activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How do steroids work in SLE?

A

inhibit NFkB with subsequent pDC death and reduced IFN production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Why may SLE patietns require higher than usual doses of steroids?

A

engagement of TLR7 and TLR9 after endosomal uptake of nucleic acid containing immune complexes promotes pDC survival and IFN production via activation of NFkB, overcoming IFN production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How is B cell tolerance defective in SLE?

A

at several levels both in central and peripheral selection responsible for removal of self-reactive immature B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What ultimately promotes activation and surviial of autoreactive B cells?

A

aberrant tolerance; enhanced BCR; TLR and BAFF receptor receptor signalling in lupus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What suggests taht the pathogenic autoantibodies are products of the gereminal centre?

A

they are high affinity; somatically mutated; Ig-switched

32
Q

How have Tfh been linked to SLE?

A

in mouse models, dysregulation of Tfh cells that promote B cell differentation in GCs is associated with SLE development

33
Q

How is BAFF realted to SLE?

A

there are increased levels of BAFF in SLE patietns and indeed correlate with disease activity

34
Q

What suggets that TLR4 and TLR2 are important in the pathogenesis of SLE?

A

expression levels in PBMCs is much higher, TLR4 deficiency downregulated the production of autoantibodies and attenuates renal injury in mouse lupus ; TLR4 upregulation is a potent trigger to induce lupu-like autoimmune disease

35
Q

How may TLR4 and TLR2 be involved in pathogenesis?

A

by binding HMGB1 which binds with DNA and thereby stimulating pathogenic anti-DNA autoantibodes

36
Q

What is the effect of TLR engagaement on B cells?

A

increases BCR signalling and antibody production

37
Q

What is the effect of IFNa on DCs?

A

increase BAFF secretion and activation

38
Q

What is SLE?

A

an autoimmune disease that can affect many organs including hte skin, joints CNS and kidneys typically affecting women of child-bearing age

39
Q

What are the potential environmental factors that predispose to SLE?

A

UV light exposure; EBV infection; endogenous retroviral sequences; drugs and hormonal factors—result in immune dysregulation of cytokines; T cells; B cells and macrophages

40
Q

What is the only drug to be approved for SLE in the past 60 years?

A

belimumab

41
Q

What makes drug trials in SLE difficult?

A

the heterogeneity of SLE–due to defects in many partso the immune cascade?

42
Q

What is the concordance rate for SLE in MZ twins?

A

25%

43
Q

Give an example of a other mutations aart from in complement which GWAS studies have implicated in SLE?

A

interferon regulatory factor 5- increased levels of type I IFN

44
Q

What suggests a role for hormones in SLE?

A

female preponderance; when patients with SLE are given HRT, risk of flare increases

45
Q

What ethnicity have higher rates of SLE?

A

afro-caribbeans

46
Q

What is one of the strongest predicotrs of increased mortality risk with SLE?

A

lupus nephritis

47
Q

What are the main causes of mortality in SLE patietns?

A

infection; CVD (esp. later in disease course)

48
Q

What suggests that the development of an inappropriate immune response is not the only mechanism in developing SLE?

A

production of antibodes against nucliec acid containing cellular particles is common in the general population

49
Q

What are the determinants of progression to SLE ?

A

genetic susceptibility factors that shape immune function; sex and stochastic factors that affect responses to exogenous or endogenous triggers

50
Q

What type of infection do the immune alterations observed in SLE show similarity to?

A

chronic immune response assocaited with models of viral infection

51
Q

What immune alterations seen in SLE are similar to chronic virus infection?

A

sustained expression of type I IFNs; increased and sustained production of pro-inflam mediatorsl; altered expression of PDL1; TRAIL; shift in T cell differentation towards Tfh cell

52
Q

What is the result of the immune alterations seen in SLE that are similar to chronic viral infection?

A

sustained and poorly regulated macrophage activation; impaired T cell function and regulation of cell death; excessive B cell differentiation; production of autoantibodies and immune complexes and widespread tissue and organ inflam and damage

53
Q

Apart from its role in clearance of apoptotic cell debris, what other protective role may C1q play in SLE?

A

directing stimulatory ICs to monocytes rather than IFNa-producing plasamcytoid DCs

54
Q

What suggests taht an X-chromosome gene-dose effect is an important contributor in SLE susceptibility?

A

Klinefelter syndrome is increased 14-fold amon men with SLE compared with men without SLE (47XXY)

55
Q

What may be the relationship between EBV and SLE?

A

T cell repsonse may be defective- increased EBV infected mononuclear cells nad increased EBV DNA; contribute to innate immune system activation and B cell differentiaion

56
Q

What led to the suggest that a viral infection may trigger SLE?

A

clinical manifestations present at diagnosis- joint pains and fatigue

57
Q

What do antibodies specific for EBNA1 corssreact with?

A

dsDNA- EBV can induce an autoimmune repsonse (common conformational epitopes)

58
Q

Why do UV and drugs contribute to the pathogenesis of SLE?

A

UV induces DNA breaks that may alter gene expression; generate nucleic acid fragments or lead to apoptotic or necrotic cell death; hydralazine results in altered DNA methylation

59
Q

How do nucleic acid containing immune complexes contribute to innate immune system activation?

A

activate nucleic acid -repsonsive endosomal TLRs leading to type I IFN procuction

60
Q

What confirms the role of immune complexes in type I IFN procuction?

A

increased expression of type I IFN0induible genes in PBMCs; autoantibodes with specific for DNA-binding proteins are strongly associated with high IFN signature

61
Q

What is the effect of IFNa on driving disease?

A

activated DCs and promotes their capacity to present antigens to T cells

62
Q

What dysfunctions in T cells have been documented in SLE patients?

A

deficiencies or alterations in T cell signalling, in the production of cytokines, in proliferation and regulatory functions - express CD40L after activation and maintain this expression longer than normal- extra help for activation and differentiation of B cells

63
Q

What type of T cell is increased in SLE?

A

Tfh cells-rpomote differentation of autoantibody-producing B cells

64
Q

What is seen in populations of Treg and Th17 in SLE?

A

reduced Tregs; increased Th17 and increased IL-17–functional consequences aren’t clear

65
Q

Why might there be reduced Tregs in SLE?

A

decreased production of IL-2 is characteristic of T cells

66
Q

What B cell factors are increased in SLE?

A

IL-21 and BAFF

67
Q

Give examples of some difference in B cells in SLE compared with normal?

A

decreased expression of inhibitory Fc receptor; altered cytokine production when engaged by nucleic-acid containing immune complexes

68
Q

Why are the anti-Sm and anti-Ro antibodies refractory to therapy?

A

produced by long-lived plasma cells which are maintained by chemokines and stromal cell products in protective bone marrow niches

69
Q

What is a protective role of antibodies in SLE?

A

natural IgM react with apoptotic cells and inihbit their activation through TLRs

70
Q

What may contribute to the increased CVS risk in SLE?

A

icnreased IFNs may contribute to impaired endotehlial repair after vascular damage; increased adgesion molecules

71
Q

Which patients is belimumab more effective in?

A

patients with higer disease activity, anti-dsDNA positivity and low complement levels

72
Q

What suggests taht low dose glucocorticoid regimes should be used, eve in renal SLE?

A

reduce steroid comorbidities and patietns treated with lower-dose steroids do not have worse sytmpoms

73
Q

Why is ritixumab an enigma?

A

several case reports have suggested benefit in resistant lupus nephritis but RCT have showed no benefit- the way the trial was done?

74
Q

What are some future strategies in SLE?

A

early detection of damage- new biomarkers eg urinary VCAM1 which correlates with renal damage and activity; or TWEAK which reflects renal flares

75
Q

What is the lipid paradox in SLE?

A

CVD risk can be higher in those with lower total and LDL cholesterol- uncertainty about which parameters are best to modify

76
Q

Give examples of agents in clinical development for SLE?

A

anti-CD22; IFN atagonists; IL-6 and blockers